Xeos is a MedTech start-up company based in Belgium, with a mission to revolutionize Surgical Oncology through innovative molecular intra-operative imaging. Their slogan, "Precisely where it matters," encapsulates their dedication to improving outcomes in surgery by aiming to eliminate the risk for re-surgery through smarter specimen imaging. Founded in 2022, Xeos is driven by the commitment to leverage cutting-edge technologies to make a significant impact in the field of healthcare. With a focus on precise and targeted solutions, Xeos is poised to attract the attention of venture capital firms seeking investment opportunities in the MedTech sector, presenting a potential for significant growth and disruption in the industry.
There is no investment information
No recent news or press coverage available for XEOS.